Skip to main content
    S

    Sonida Senior Living Inc (SNDA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $32.91
    -0.09 (-0.27%)

    Market Cap: $1.62B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sonida Senior Living Inc (SNDA) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Sonida Senior Living (SNDA) trades at 2.5x sales and 1.8x book value. Its P/S of 2.5x is above its 5-year median of 0.9x. Its forward P/E is 57.1x.

    Current Multiples

    Its enterprise value is 59.3x its EBITDA.

    MultipleValue
    P/E (trailing)N/A
    Forward P/E57.1x
    Price to sales2.5x
    Price to book1.8x
    EV/EBITDA59.3x
    PEGN/A
    FCF yield-3.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 316.7% above 0.6x.

    MultipleCurrent5-year median10-year median
    P/S2.5x0.9x0.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 110 months (10-year).

    Valuation History

    Over the 9 of the 10 year ends shown that have a P/S, its P/S ranged from 0.2x in 2019 to 1.6x in 2017.

    Year endPriceP/EP/SP/B
    2025$32.61N/A1.5x11.5x
    2024$23.08N/A1.0x3.4x
    2023$9.66N/A0.3xN/A
    2022$12.50N/A0.3xN/A
    2021$28.490.5x0.2xN/A
    2020$12.34N/AN/AN/A
    2019$46.33N/A0.2x6.5x
    2018$101.95N/A0.4x5.8x
    2017$202.25N/A1.6x5.0x
    2016$240.63N/A1.4x4.0x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SNDA

    What is SNDA's forward P/E ratio?

    Sonida Senior Living has a forward P/E ratio of 57.1x.

    Is SNDA stock overvalued?

    GNG's valuation label for SNDA is Overvalued.

    What is SNDA's price to sales ratio?

    Sonida Senior Living has a price to sales ratio of 2.5x.